NCT01567865View on ClinicalTrials.gov

Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine

PHASE4CompletedINTERVENTIONAL

Enrollment

818

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

Vaccine produced in existing facility

Live attenuated Japanese encephalitis vaccine SA 14-14-2 (LJEVac) produced in the existing facility by the Chengdu Institute of Biological Products (CDIBP), Chengdu, China

BIOLOGICAL

Vaccine produced in new facility

Live attenuated Japanese encephalitis vaccine SA 14-14-2 (LJEVac) produced in the new facility by the Chengdu Institute of Biological Products (CDIBP), Chengdu, China

Trial Locations (1)

Unknown

ICDDR,B, Dhaka

All Listed Sponsors

lead

PATH

OTHER

NCT01567865 - Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine | Biotech Hunter | Biotech Hunter